跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 485 条关于
“IgA1”
全部
485
临床试验
363
药物
28
机构
0
资讯
94
去年
Biohaven's BHV-1400 Demonstrates Rapid Reduction of Gd-IgA1 in Phase 1 Trial for IgA Nephropathy
去年
Felzartamab Shows Promise in Reducing Proteinuria in IgA Nephropathy Patients
去年
Paradigm Shift in IgA Nephropathy Treatment: Novel Targeted Therapies Address Disease Mechanisms
10个月前
Sibeprenlimab Demonstrates 54% Proteinuria Reduction in Largest Phase 3 IgA Nephropathy Trial
4年前
Phase II Study Shows Atacicept's Potential in Treating IgA Nephropathy
3年前
Targeting the Endothelin A Receptor in IgA Nephropathy: A New Therapeutic Approach
去年
Otsuka Submits BLA for Sibeprenlimab: A Novel Targeted Therapy for IgA Nephropathy
5个月前
Calliditas Therapeutics Presents New NefIgArd Trial Data Supporting Nefecon's Gut-Targeted Mechanism in IgA Nephropathy
9天前
FDA Clears IND for Alebund's First-in-Class IgA Protease AP308 in IgA Nephropathy
去年
Atacicept Shows Sustained eGFR Stabilization in IgAN Patients Over 96 Weeks
第 1 页,共 10 页
上一页
下一页